Skip to main content
Clinical Trials/NCT04533256
NCT04533256
Completed
Not Applicable

Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis

Institutul Clinic Fundeni1 site in 1 country30 target enrollmentJuly 10, 2016
ConditionsSepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Institutul Clinic Fundeni
Enrollment
30
Locations
1
Primary Endpoint
28-days mortality
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Hemoadsorption has been demonstrated to improve clinical and paraclinical results in critically ill patients with sepsis and septic shock. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with sepsis, on organ failure, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.

Registry
clinicaltrials.gov
Start Date
July 10, 2016
End Date
July 30, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Popescu Mihai

clinical professor

Institutul Clinic Fundeni

Eligibility Criteria

Inclusion Criteria

  • patients with sepsis or septic shock who require hemoadsorption in accordance with local guidelines

Exclusion Criteria

  • unsigned informed consent
  • duration of therapy under 12 hours
  • death before the three consecutive sessions

Outcomes

Primary Outcomes

28-days mortality

Time Frame: 28 days after ICU admission

28-days mortality

Secondary Outcomes

  • severity score(3 days)

Study Sites (1)

Loading locations...

Similar Trials